Analysis of innovative development strategies in pharmacy

Authors

DOI:

https://doi.org/10.15587/2519-4852.2017.119091

Keywords:

patent, drug, biosimilar, orphan drug, antiretroviral drug, state-private partnership

Abstract

The aim of the work is to analyze and systematize existing scientific approaches and mechanisms for the formation of innovation development strategies in pharmacy.

Materials and methods. Studies were conducted using a database on the Internet: Ukrainian patent office, SE “The State Expert Center” of the Ministry of Health of Ukraine, scientometric databases. Retrospective, systematic and analytical methods were been used.

Results. It has established that the most perspective directions of innovation development in pharmacy are: the search of priority therapeutic directions, where there is a low level of health care satisfaction, in effective and safe drugs; development of biosimilars; nanotechnology-based drugs; orphan drugs; antiretroviral drugs. Prospective strategies for patent protection prolongation of intellectual property objects in pharmacy have been analyzed and determined, which is an essential condition for the creation of effective mechanisms for their commercialization. It has proved actuality of the use state-private partnership mechanisms in Ukraine for modernization of health care system and pharmacy. This will increase the investment attractiveness of the pharmaceutical industry for foreign investors and international organizations, stimulating of innovation processes.

Conclusions. The rational choice of innovation strategy allows pharmaceutical companies to maintain and expand the quality and effectiveness of innovation, to bring new, original pharmaceutical drugs in different pharmaceutical forms available to the general population

Author Biographies

Elena Litvinova, National University of Pharmacy Pushkinska str., 53, Kharkiv, Ukraine, 61002

PhD, Associate Professor

Department of Management and Economics of Enterprise

Olga Posilkina, National University of Pharmacy Pushkinska str., 53, Kharkiv, Ukraine, 61002

Doctor of Pharmaceutical Sciences, Professor

Department of Management and Economics of Enterprise

References

  1. Farmatsiia XX stolittia: tendentsii ta perspektyvy (2016). Kharkiv: NFaU, 1, 458.
  2. Dmitrik, E. (2015). Struktura rynka lekarstvennykh sredstv v razreze rynochnogo statusa. Ezhenedel'nik Apteka, 1009 (38). Available at: http://www.apteka.ua/article/346577
  3. Shelepko, S. (2015). Zaglyadyvaya v budushhee: blokbastery i perspektivnye R&D – novinki 2015 g. Ezhenedel'nik Apteka, 973 (2). Available at: http://www.apteka.ua/article/320463
  4. Shelepko, S., Luk'yanchuk, E. (2016). Biosimilyary na evropeyskom farmrynke: kakovy uspekhi i perspektivy? Ezhenedel'nik Apteka, 976 (5). Available at: http://www.apteka.ua/article/322521
  5. Piminov, A. F. (Ed.) (2014). Nanotekhnologii v farmatsii i meditsine. Kharkiv: Izd-vo Fakt, 672.
  6. Shelepko, S. (2017). Rynok orfannykh preparatov: kakie faktory obuslovlivayut rost? Ezhenedel'nik Apteka, 1084 (13). Available at: http://www.apteka.ua/article/404764
  7. Antunes, A., Fierro, I., Guerrante, R., Mendes, F., Alencar, M. (2013). Trends in Nanopharmaceutical Patents. International Journal of Molecular Sciences, 14 (4), 7016–7031. doi: 10.3390/ijms14047016
  8. Giannuzzi, V., Conte, R., Landi, A., Ottomano, S. A., Bonifazi, D., Baiardi, P. et. al. (2017). Orphan medicinal products in Europe and United States to cover needs of patients with rare diseases: an increased common effort is to be foreseen. Orphanet Journal of Rare Diseases, 12 (1), 64–69. doi: 10.1186/s13023-017-0617-1
  9. Clark, L., Beadle, D. (2012). Patent term extensions: issues, challenges and implications for pharmaceuticals. Pharmaceutical Patent Analyst, 1 (4), 427–435. doi: 10.4155/ppa.12.47
  10. Cockburn, I., Long, G. (2015). The importance of patents to innovation: updated cross-industry comparisons with biopharmaceuticals. Expert Opinion on Therapeutic Patents, 25 (7), 739–742. doi: 10.1517/13543776.2015.1040762
  11. Dmitrik, E. (2017). Gosudarstvenno-chastnoe partnerstvo v sfere zdravookhraneniya. Mezhdunarodnyy opyt. Ezhenedel'nik Apteka, 1104 (33). Available at: http://www.apteka.ua/article/423444

Downloads

Published

2017-12-31

How to Cite

Litvinova, E., & Posilkina, O. (2017). Analysis of innovative development strategies in pharmacy. ScienceRise: Pharmaceutical Science, (6 (10), 17–20. https://doi.org/10.15587/2519-4852.2017.119091

Issue

No. 6 (10) (2017)

Section

Pharmaceutical Science

License

Copyright (c) 2018 Elena Litvinova, Olga Posilkina

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons Attribution 4.0 International License copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.

3. Authors have the right to store the final accepted version of the article in an institutional, thematic, or any other repository to ensure visibility and accessibility.